Table 1 Change of hepatitis B serological markers in the clinical course
Recipient | Donor | |||||||
|---|---|---|---|---|---|---|---|---|
Viral marker | Before LDLT | After LDLT | After antiviral therapy | Before anti-rejection therapy | After anti-rejection therapy | Before 1-year cessation | After 1-year cessation | Before donation |
HBsAg (IU/ml) | 0.29 | 99.9 | >2000.0 | >2000.0 | 146.9 | 177.6 | 0.01 | 0.25 |
HBsAb (mIU/ml) | 0.26 | 0.0 | 0.3 | 0.1 | 5.0 | 5.0 | 19.2 | 35.46 |
HBeAg | − | + | + | + | + | + | − | − |
HBeAb | − | − | − | − | − | − | − | − |
HBcAb | − | + | + | + | + | + | + | + |
HBV-DNA (log copies/ml) | <2.6 | >7.6 | <2.6 | <2.6 | <2.6 | <2.6 | <2.1 | <2.6 |